The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid Carcinoma
Abstract
BACKGROUND: Distant metastasis is uncommon in differentiated thyroid cancer and the prognosis is unclear. This study aims to evaluate outcomes and to define independent variables that are associated with tumor-related mortality in patients with distant metastasis from thyroid carcinoma. STUDY DESIGN: A retrospective review of the thyroid cancer research database identified 336 patients with distant metastasis from differentiated thyroid carcinoma treated at a single institution between 1941 and 2000. After excluding patients with local or regional recurrence, distant disease was either the first site of recurrence or was detected at the time of diagnosis of the primary tumor in 242 patients (72%). Patient, tumor, and treatment-related factors were analyzed for their relation to disease-specific survival (DSS) using multivariate Cox regression and the log-rank test. RESULTS: Median survival was 4.1 years and 10-year DSS was 26%. Distant disease was synchronous with the primary diagnosis in 97 of 242 (40%) patients. The site of metastasis was lung only in 103 (43%) patients, bone only in 80 (33%), other sites in 14 (6%), and more than one organ system in 45 (19%). Multivariate analysis identified age 45 years or more, symptoms, site other than lung only or bone only, and no radioactive iodine treatment for the metastasis as predictors of poor outcome with 13%, 11%, 16%, and 12% 10-year DSS, respectively. This compares with age less than 45 years, asymptomatic presentation, metastasis only in the lung or bone, and radioactive iodine treatment with 10-year DSS rates of 58%, 45%, 32%, and 33%, respectively (all p < 0.0001). Radioactive iodine treatment was more often given in patients who were less than 45 years of age, asymptomatic, and with metastasis only in the lung or bone only (p = 0.03, 0.11, 0.01). CONCLUSIONS: Longterm survival is possible in patients with distant metastasis from differentiated thyroid cancer. This retrospective study found that age of 45 years or more, site other than lung only or bone only, and symptoms at the time of diagnosis are associated with poorer outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.51.1.15 · Cited by 3,288
MARTIN, S., MAURICE, T., VATHAIRE, F. D., CATHERINE, H., GARDET, P., TRAVAGLI, J.-P., FRAGU, P., LUMBROSO, J., CAILLOU, B., & PARMENTIER, C. (1986) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-63-4-960 · Cited by 552
RUEGEMER, J. J., HAY, I. D., BERGSTRALH, E. J., RYAN, J. J., OFFORD, K. P., & GORMAN, C. A. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-3-501 · Cited by 389
Differentiated thyroid cancer presenting initially with distant metastasis
R. Shaha, A., P. Shah, J., & R. Loree, T. (1997) · The American Journal of Surgery · doi:10.1016/s0002-9610(97)00158-x · Cited by 273
Impact of Therapy for Differentiated Carcinoma of the Thyroid: An Analysis of 706 Cases*
Samaan, N. A., Maheshwari, Y. K., Nader, S., Hill, C. S., Schultz, P. N., Haynie, T. P., Hickey, R. C., Clark, R. L., Goepfert, H., Ibanez, M. L., et al. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1131 · Cited by 270
Pittas, A. G., Adler, M., Fazzari, M., Tickoo, S., Rosai, J., Larson, S. M., & Robbins, R. J. (2000) · Thyroid · doi:10.1089/thy.2000.10.261 · Cited by 224
La Quaglia, M. P., Black, T., Holcomb, G. W., Sklar, C., Azizkhan, R. G., Haase, G. M., & Newman, K. D. (2000) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2000.6935 · Cited by 173
Recurrent Thyroid Cancer Role of Surgery Versus Radioactive Iodine (I131)
Coburn, M. C., Teates, D., & Wanebo, H. J. (1994) · Annals of Surgery · doi:10.1097/00000658-199406000-00001 · Cited by 110
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Cooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Sherman, S. I., & Tuttle, R. M. (2006) · Thyroid · doi:10.1089/thy.2006.16.109 · Cited by 2,016
Brose, M. S., Nutting, C. M., Jarzab, B., Elisei, R., Siena, S., Bastholt, L., de la Fouchardiere, C., Pacini, F., Paschke, R., Shong, Y. K., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60421-9 · Cited by 1,663
Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy
Jonklaas, J., Sarlis, N. J., Litofsky, D., Ain, K. B., Bigos, S. T., Brierley, J. D., Cooper, D. S., Haugen, B. R., Ladenson, P. W., Magner, J., et al. (2006) · Thyroid · doi:10.1089/thy.2006.16.1229 · Cited by 695
Metadata
- Authors
- Shoup, M., Stojadinovic, A., Nissan, A., Ghossein, R. A., Freedman, S., Brennan, M. F., Shah, J. P., & Shaha, A. R.
- Venue
- Journal of the American College of Surgeons
- Published
- 2003-08
- Volume
- 197
- Issue
- 2
- Pages
- 191-197
- ISSN
- 1072-7515 (ISSN-L)
- OpenAlex
- W2036910930
- Cited by
- 280
- References
- 8
- FWCI
- 5.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid Carcinoma. https://app.cochat.ai/papers/10.1016/s1072-7515(03)00332-6
- The paper
- Shoup, M., Stojadinovic, A., Nissan, A., Ghossein, R. A., Freedman, S., Brennan, M. F., Shah, J. P., & Shaha, A. R. (2003). Prognostic Indicators of Outcomes in Patients with Distant Metastases from Differentiated Thyroid Carcinoma. Journal of the American College of Surgeons. https://doi.org/10.1016/s1072-7515(03)00332-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.